April 15, 2026
driving biofuels growth and investment strategy from London

Alkagesta continues to advance its global energy transition strategy with focused investment in bio-feedstocks within its biofuels portfolio, led by the experienced investment management team of Alkagesta UK.

LONDON, Oct. 14, 2025 /PRNewswire/ — Established in 2024, Alkagesta UK operates at the nexus of M&A activity, capital flows, and investment structuring. The subsidiary was formed by onboarding a leadership team from Bulge Bracket investment banking and global multi-asset brokerage firms, bringing deep expertise in governance, risk management, and long-term investment strategy—aimed at reinforcing Alkagesta’s trading competencies through strategic asset acquisition and financial discipline.

Alkagesta UK: driving biofuels growth and investment strategy from London
Alkagesta UK: driving biofuels growth and investment strategy from London

“London offers a unique blend of financial sophistication and institutional trust. Alkagesta UK was built to harness that environment for disciplined growth and long-term value creation. Our ambition is to scale non-organically by aligning structured investments with the energy transition,” said Orkhan Rustamov, CEO of Alkagesta.

This move reflects Alkagesta’s ongoing commitment to sustainable financial growth within the global commodities industry. The leadership team driving non-organic growth brings extensive experience in structured finance, institutional relationship management, and capital markets.

The UK subsidiary represents a strategic step toward consolidating and aligning investment decision-making across Alkagesta’s international offices. Operating within one of the world’s most mature financial ecosystems, Alkagesta UK benefits from proximity to leading advisors, legal experts, and institutional investors—creating a robust platform for executing cross-border transactions and structured deals.

In the first half of 2025 alone, the UK investment sector recorded over £71 billion in disclosed deal value, with nearly 88% of transactions falling within the sub-£100 million range (MarketIQ Report, H1 2025). Private equity activity surged, accounting for 72% of all deals—a 90% increase over the previous year. This dynamic environment reinforces London’s role as a global hub for strategic capital deployment, making it an ideal base for Alkagesta’s expansion into structured finance and ESG-aligned investments.

“Governance and risk management are not just safeguards—they’re strategic enablers. Alkagesta UK was designed to embed these principles into every investment decision, ensuring resilience and credibility across our global operations,” noted Mark Seccombe, Board Member, Alkagesta.

link